Potential Prospect of CDK4/6 Inhibitors in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive, difficult-to-treat subtype of cancer with a poor prognosis; there is an urgent need for effective, targeted molecular therapies. The cyclin D/cyclin-dependent kinase (CDK)4/6–retinoblastoma protein (Rb) pathway plays a critical role in regulatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ye, Gao, Jiyue, Wang, Meiling, Li, Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257068/
https://www.ncbi.nlm.nih.gov/pubmed/34234565
http://dx.doi.org/10.2147/CMAR.S310649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257068/
https://www.ncbi.nlm.nih.gov/pubmed/34234565
http://dx.doi.org/10.2147/CMAR.S310649

Ejemplares similares